ONWARD Medical
European medtech company developing spinal cord stimulation therapies that restore movement and function after spinal cord injury, integrated with BCI technology.
Overview
ONWARD Medical is a leading European neuromodulation company developing therapies to restore movement, independence, and health in people with spinal cord injury. Listed on Euronext (ONWD), the company has advanced from academic research at EPFL (Swiss Federal Institute of Technology in Lausanne) to commercial-stage medical devices.
BCI Integration
In September 2024, ONWARD demonstrated brain-computer interface technology integrated with spinal cord stimulation, enabling a patient to control movement restoration through thought alone. This combination of BCI decoding with targeted spinal stimulation represents a significant advance in closed-loop neurorehabilitation.
Products
The company’s ARC Therapy platform delivers targeted spinal cord stimulation to restore motor function. The technology has shown results in enabling patients with complete spinal cord injury to stand, walk, and regain autonomic functions including blood pressure regulation and bladder control.
European Leadership
As the most advanced European BCI-adjacent company, ONWARD Medical demonstrates that significant neurotechnology innovation extends beyond the US-China axis. The company’s EPFL origins and Euronext listing establish a European framework for neurotech commercialization.